Application no. and date | 20708762.8 (espacenet) (Federated) (European Patent Register), 20200124 | Patent/reg. no. and date | DK/EP 3914617, 20240313 | Publication date | 20211201 | Priority no. and date | US 201962796953 P, 20190125 | EP pub. no. and date |
EP 3914617 20211201 | Effective date | | Applicant/owner | Alexion Pharmaceuticals, Inc., 121 Seaport Boulevard
Boston, MA 02210, US | Applicant ref. no. | 1707169 | Inventor | GAO, Xiang, 7 Franklins Way
Guilford, CT 06437, US, PAYTON, Lori, 45 Wickford Place
Madison, CT 06443, US, PRADHAN, Rajendra, 254 College Street Apt. 4B
New Haven, CT 06510, US, MIX, Christian, 24 Atwood Street
Wellesley, MA 02481, US, DAMOKOSH, Andrew, 115 Waterside Lane West
Hartford, CT 06107, US, SWENSON, Eugene Scott, 102 Yankee Peddler Path
Madison, CT 06443, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61P 7/00 (2006.01) , C07K 16/18 (2006.01) , C07K 16/28 (2006.01) , C07K 16/40 (2006.01) , C07K 16/46 (2006.01) | Title | DOSERING OG ADMINISTRATION AF ANTI-C5-ANTISTOFFER TIL BEHANDLING AF ATYPISK HÆMOLYTISK URÆMISK SYNDROM (AHUS) | Int. application no. | US2020014998 | Int. publication no. | WO2020154626 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|